Could the Inflation Reduction Act Maximum Fair Price Hurt Patients?

**Background:** The Inflation Reduction Act’s Medicare Drug Price Negotiation Program allows the federal government to negotiate caps for select medications. These price caps may reduce revenue for the pharmacy benefit managers (PBMs) that negotiate the actual price paid for medicines in the U.S. To...

Full description

Saved in:
Bibliographic Details
Main Authors: Anne M. Sydor, Esteban Rivera, Robert Popovian
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2024-11-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/001c.125251
Tags: Add Tag
No Tags, Be the first to tag this record!